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The ORCA2 transcription factor plays a key role in
regulation of the terpenoid indole alkaloid
pathway
Chun Yao Li1, Alex L Leopold1, Guy W Sander2, Jacqueline V Shanks3, Le Zhao3 and Susan I Gibson1*
Abstract
Background: The terpenoid indole alkaloid (TIA) pathway leads to the production of pharmaceutically important
drugs, such as the anticancer compounds vinblastine and vincristine. Unfortunately, these drugs are produced in
trace amounts, causing them to be very costly. To increase production of these drugs, an improved understanding
of the TIA regulatory pathway is needed. Towards this end, transgenic Catharanthus roseus hairy roots that
overexpress the ORCA2 TIA transcriptional activator were generated and characterized.
Results: Transcriptional profiling experiments revealed that overexpression of ORCA2 results in altered expression of
key genes from the indole and terpenoid pathways, which produce precursors for the TIA pathway, and from the
TIA pathway itself. In addition, metabolite-profiling experiments revealed that overexpression of ORCA2 significantly
affects the levels of several TIA metabolites. ORCA2 overexpression also causes significant increases in transcript
levels of several TIA regulators, including TIA transcriptional repressors.
Conclusions: Results presented here indicate that ORCA2 plays a critical role in regulation of TIA metabolism.
ORCA2 regulates expression of key genes from both feeder pathways, as well as the genes (STR and SGD) encoding
the enzymes that catalyze the first two steps in TIA biosynthesis. ORCA2 may play an especially important role in
regulation of the downstream branches of the TIA pathway, as it regulates four out of five genes characterized from
this part of the pathway. Regulation of TIA transcriptional repressors by ORCA2 may provide a mechanism whereby
increases in TIA metabolite levels in response to external stimuli are transient and limited in magnitude.
Keywords: Terpenoid indole alkaloids, ORCA2, Catharanthus roseus, Hairy root cultures
Background
The plant Catharanthus roseus (L.) G. Don (Madagascar
periwinkle) produces a large number of terpenoid indole
alkaloids (TIAs), some of which are of substantial pharma-
cological interest. Vinblastine and vincristine have been
used as chemotherapeutics in the treatment of lymphoma
and leukemia [1]. Ajmalicine and serpentine are sometimes
used as anti-hypertensive agents. Most of these alkaloids
are produced in extremely low amounts in planta, limiting
the usage of these chemicals. Substantial efforts to use
chemical syntheses, in vitro cell cultures or bacterial cells
for large-scale production of these alkaloids have proven in-
effective [2,3]. One of the difficulties in developing methods
for large-scale production of TIAs is the complexity of both
the TIA biosynthetic pathway and of the regulatory path-
ways governing TIA production. Despite the complexity of
these pathways, significant progress in our understanding
of the biochemistry and regulation of the TIA pathway
in C. roseus has been made in recent years. In particular,
many of the genes coding for the TIA biosynthetic enzymes
and TIA transcriptional activators and repressors have
been identified [4-9].
TIA biosynthesis is a tightly coordinated process involv-
ing at least 35 intermediates, 30 biosynthetic enzymes and
several intra and inter cellular compartments [3,10,11]. TIA
biosynthesis in C. roseus starts with the condensation of
tryptamine, which is derived from the indole pathway, and
secologanin, which is derived from the monoterpenoid
pathway, to form strictosidine (Figure 1). This reaction
is catalyzed by strictosidine synthase (STR). Strictosidine is
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then deglucosylated by strictosidine β-D-glucosidase
(SGD) to form cathenamine and an equilibrium between
cathenamine and 4,21-dehydrogeissoschizine is established
[12]. Different branches of the TIA pathway then lead
to the production of numerous TIAs, including ajmalicine
and serpentine, lochnericine and hörhammericine, and
catharanthine and vindoline. Vindoline and catharanthine
are the precursors of vinblastine and vincristine. The
genes encoding the enzymes catalyzing at least four of
the reactions in the six-step pathway leading to production
of vindoline from tabersonine have been cloned and char-
acterized. These genes include tabersonine 16-hydroxylase
(T16H) [13], 16-hydroxytabersonine-16-O-methyltransferase
(16OMT) [14], desacetoxyvindoline 4-hydroxylase (D4H)
[15], and deacetylvindoline acetyltransferase (DAT) [16].
An enzyme with anhydrovinblastine synthase activity that
catalyzes the synthesis of α-3′, 4′-anhydrovinblastine from
vindoline and catharanthine has also been identified and
characterized as the major class III peroxidase (PRX1)
in C. roseus leaves [17].
TIA biosynthesis is a highly regulated process that
involves a number of transcriptional activators and repres-
sors. To date, seven putative activators (ORCA2, ORCA3,
CrBPF1, CrMYC1, CrMYC2, CrWRKY1 and CrWRKY2)
and five putative repressors (ZCT1, ZCT2, ZCT3, GBF1
and GBF2) have been implicated as regulators of the
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Figure 1 TIA biosynthesis in C. roseus. Enzyme abbreviations are written in capital letters next to the arrow indicating the reaction catalyzed
by each enzyme. The metabolites resulting from different enzymatic conversions are indicated by the appropriate arrows. Solid arrows represent
single enzymatic conversions, whereas dashed arrows indicate multiple enzymatic reactions. The genes that were included for analysis of
expression are marked in bold. 16OMT, 16-hydroxytabersonine-O-methyl-transferase; AS, anthranilate synthase; CPR, cytochrome P450 reductase;
CYP71BJ1, CYP71 cytochrome P450 hydroxylase; D4H, desacetoxyvindoline 4-hydroxylase; DAT, deacetylvindoline 4-O-acetyltransferase; DMAPP,
dimethylallyl pyrophosphate; DXS, 1-deoxy-D-xylulose-5-phosphate synthase; G3P, glyceraldehyde 3-phosphate; G10H, geraniol 10-hydroxylase;
IPP, isopentenyl diphosphate; LAMT, loganic acid O-methyltransferase; PRX1, vacuolar class III peroxidase; SGD, strictosidine glucosidase; SLS,
secologanin synthase; STR, strictosidine synthase; T6,7E, tabersonine 6,7-epoxidase; T16H, tabersonine 16-hydroxylase; TDC,
tryptophan decarboxylase.
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TIA pathway. However, very few studies have been done
on any of these regulators, with the exception of ORCA3
[7-9,18-24]. Both ORCA2 (Octadecanoid-Responsive
Catharanthus AP2-domain protein 2) [18] and ORCA3
[22] are AP2-domain transcription factors that are
proposed to activate STR expression by binding to the
jasmonate and elicitor-responsive element (JERE) in
the STR promoter [18,22]. CrBPF1 is also proposed to
activate STR transcription by binding to a separate element
in the STR promoter [24]. CrMYC1 [23] and CrMYC2 [7]
are basic helix-loop-helix transcription factors. CrMYC2
has been shown to act upstream of ORCA2 and ORCA3,
activating their transcription [7]. CrWRKY1 and CrWRKY2
are jasmonate responsive WRKY transcription factors
that positively regulate expression of several genes involved
in TIA biosynthesis [8,9]. Overexpression of CrWRKY1
also leads to increased transcript levels of the TIA
transcriptional repressors ZCT1, ZCT2 and ZCT3 and
decreased transcript levels of the TIA transcriptional
activators ORCA2, ORCA3 and CrMYC2 [9]. In contrast,
overexpression of CrWRKY2 leads to increased expression
of both specific TIA transcriptional activators (ORCA2,
ORCA3 and CrWRKY1) and repressors (ZCT1 and ZCT3)
[8]. The three zinc finger proteins, ZCT1, ZCT2, and
ZCT3, were found to bind specifically to the tryptophan
decarboxylase (TDC) and STR promoters in vitro, inhibiting
their activities. In addition, the ZCT proteins repress the
activation of the STR promoter by the ORCAs [19]. Two
G-box-binding factors, GBF1 and GBF2, were found to
repress STR transcription by binding to the G-box sites
in the STR promoter region [20].
The identification of multiple transcriptional activa-
tors and repressors for the TIA pathway suggests that
regulation of this pathway is a complex process. However,
to date there have been very few published studies de-
scribing in depth characterization of TIA regulators other
than ORCA3. ORCA3 has been the focus of several studies
in recent years. The results of these studies indicate
that ORCA3 acts as a positive regulator of many TIA
biosynthetic genes [5,19,21,22,25-30]. For these studies
ORCA3 was overexpressed in either suspension cells or
hairy root cultures. In C. roseus cell cultures, overexpression
of ORCA3 increases the transcript levels of TDC, STR,
cytochrome P450 reductase (CPR), 1-deoxy-D-xylulose
5-phosphate synthase (DXS), anthranilate synthase α
subunit (ASα) and D4H. In contrast, overexpression of
ORCA3 in C. roseus cell suspension cultures has no signifi-
cant effects on transcript levels of geraniol 10-hydroxylase
(G10H), SGD or DAT [21]. In C. roseus hairy root cultures,
overexpression of ORCA3 induces expression of ASα, DXS,
secologanin synthase (SLS), STR and ZCT1, ZCT2 and
ZCT3, but represses SGD expression. The transcript levels
of TDC, CPR, G10H, GBF1, GBF2 and ORCA2 were not
significantly affected by ORCA3 overexpression [27].
Although several studies have characterized the role of
ORCA3 in regulating the TIA pathway, little work has
been done to characterize the role of the related ORCA2
transcriptional activator. Recently Liu et al. reported the
generation of C. roseus transgenic hairy root lines that
exhibit constitutive overexpression of ORCA2 and stated
that catharanthine and vindoline concentrations increased
in these lines, but only HPLC and an authentic standard
were used for the identification of vindoline [31]. Vinblast-
ine levels in these lines were below detection limits and
other TIA metabolites were not assayed as part of this
study. The expression levels of TIA biosynthetic genes and
of other TIA regulatory genes were also not characterized
by Liu and colleagues, leaving the role of ORCA2 in
regulating TIA metabolism unknown.
Here we describe the generation, metabolic and mo-
lecular characterization of a transgenic C. roseus hairy
root line that expresses ORCA2 under the control of
an ethanol-inducible promoter. The transcript levels of
a total of 22 TIA biosynthetic and regulatory genes
were tracked over a period of 72 h following induction
of ORCA2 overexpression. The levels of seventeen TIA
and related metabolites were also investigated over the
same time period, with thirteen of those metabolites being
present at detectable levels in at least some of the samples
analyzed. The results of these experiments indicate that
ORCA2 plays an important role in regulating the TIA
pathway, particularly the downstream portions of this
pathway. Based on the results of these experiments, a
model for regulation of the TIA pathway by ORCA2 and
other TIA transcriptional regulators is presented.
Results
Generation of C. roseus transgenic hairy root lines expressing
ORCA2 under the control of an ethanol-inducible promoter
To date, only a few studies have characterized ORCA2
[18,31] and no published studies have determined which
TIA genes, other than STR, are regulated by ORCA2 or
how ORCA2 overexpression affects the levels of a broad
group of TIA metabolites. As a result, determining the
role of ORCA2 in regulating the TIA pathway has not been
possible. To address this deficiency, transgenic hairy
root lines that overexpress ORCA2 under the control
of an ethanol-inducible promoter were generated. The
ethanol-inducible system offers significant advantages
over constitutive expression systems in that the ethanol-
inducible system allows the timing and level of transgene
expression to be controlled [32]. As a result, studies on the
transient effects of transgene expression are made possible.
In addition, the potentially deleterious effects of constitutive
overexpression of transgenes on tissue growth and develop-
ment may be mitigated.
To generate transgenic hairy roots, approximately
6-week-old C. roseus seedlings were co-transformed using
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a mixture of Agrobacterium tumefaciens GV3101 carrying
the binSRNA-ORCA2 construct (Figure 2) and GV3101
carrying the pPZPROL plasmid. The pPZPROL plasmid
was previously engineered to carry the rolA, rolB and rolC
genes that are sufficient to induce hairy root production
[33]. A total of 27 hairy root lines were screened for
genomic integration of ORCA2 by assaying for kanamycin
resistance and using PCR to identify a DNA fragment
spanning the ORCA2 gene and alcA promoter. Five of the
27 hairy root lines were found to carry ORCA2 under the
control of the alcA promoter. These positive lines were
transferred to liquid culture for adaptation. Following
adaptation, the lines were screened for ethanol-inducible
overexpression of ORCA2. Figure 3 shows ORCA2 relative
transcript levels from the five ORCA2 transgenic hairy
root lines. The results indicate that the transgenic lines ex-
press ORCA2 transcripts at approximately three to 10 times
higher levels than the control line 10 h after induction by
0.5% (v/v) ethanol. As the ORCA2-OE line exhibited one of
the highest levels of ORCA2 induction and adapted
well to liquid culture, this line was retained for further
study. A control line was also generated by transforming
C. roseus seedlings with GV3101 cells carrying the
pPZPROL construct alone.
To determine if ethanol-induced overexpression of
ORCA2 in the ORCA2-OE line is maintained for a sub-
stantial period of time, a 72-h time course was performed.
ORCA2 transcripts generated from the ORCA2 transgene
and by the endogenous ORCA2 gene were measured
separately in this experiment. An ethanol concentration of
0.02% was used for this experiment after this concentration
of ethanol was found to be sufficient to cause increases in
ORCA2 transcript levels similar to those caused by the
0.5% ethanol used in earlier experiments (data not shown).
Figure 4A shows that ORCA2 transgene transcript levels
increase dramatically after adding ethanol to ORCA2-OE
root cultures, rising over seven fold within 6 h. ORCA2
transgene transcript levels remained high in the induced
cultures over the 72-h course of the experiment. In
contrast, ORCA2 transgene transcript levels decrease
in uninduced ORCA2-OE root cultures upon transfer
to fresh media at the 0-h time point. This decrease in
ORCA2 transgene transcript levels is likely due to the
fact that plant cultures grown in liquid typically produce
small amounts of ethanol. Thus, the 35-d old cultures from
which the 0-h time point samples were collected contained
small amounts of ethanol, which likely caused a modest
induction of ORCA2 transgene expression. Transferring
additional 35-d old cultures to fresh media with no added
ethanol at the 0-h time point thus caused a slight decrease
in ethanol concentration and, consequently, in ORCA2
transgene expression in those cultures. As a result, ORCA2
transgene transcript levels are approximately 100-fold
higher in the induced than in the uninduced ORCA2-OE
cultures within approximately 12 h after induction.
The levels of ORCA2 transcripts generated from the
endogenous ORCA2 gene increase approximately three
fold after addition of ethanol to the ORCA2-OE cultures
ORCA2 alcA alcR CaMV 35S nptII 
LB RB 
binSRNA-ORCA2 
nos 
Figure 2 Schematic of binSRNA-ORCA2 overexpression
construct used for C. roseus transformation. The CaMV 35S
promoter directs transcription of the alcR gene to produce the
regulatory protein, AlcR. In the presence of its coinducer, AlcR binds
to specific regions within the alcA promoter region and induces
transcription of downstream genes [34]. As plants produce the AlcR
coinducer, acetaldehyde [35], from ethanol, this construct thus
allows ethanol-inducible expression of ORCA2. The npt11 gene codes
for kanamycin resistance. The transcription termination sequence
from the nos gene is present downstream of ORCA2. alcA, alcA
promoter sequence; alcR, alcR coding region; CaMV 35S, CaMV 35S
promoter sequence; LB, T-DNA left border sequence; nos, nopaline
synthase transcription termination sequence; ORCA2, ORCA2 cDNA
coding region; RB, T-DNA right border sequence.
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Figure 3 Relative ORCA2 transcript levels in five ORCA2 transgenic
hairy root lines. ORCA2 transcript levels were assayed in five transgenic
hairy root lines transformed with the binSRNA-ORCA2 and pPZPROL
constructs (OR6, OR13, OR17, OR21 and ORCA2-OE) and in a control line
carrying only the pPZPROL construct (Control). ORCA2 transcript levels
were measured in these lines under induced and uninduced conditions,
10 h after induction with 0.5% ethanol. Relative mRNA levels are
presented as ΔΔCT. ΔΔCT = ΔCTuninduced control line - ΔCTother line, where
ΔCT = CTORCA2 - CTEF1 and “other line” is the induced control line or
uninduced or induced cultures of one of the binSRNA-ORCA2
containing lines. Positive ΔΔCT values indicate that ORCA2 transcript
levels are higher in the indicated hairy root line grown under the
indicated conditions than in the uninduced control line. Conversely,
negative ΔΔCT values indicate that ORCA2 transcript levels are lower in
the indicated hairy root line grown under the indicated conditions than
in the uninduced control line. Results are the average ΔΔCT value of
three biological replicates, with two technical replicates for each
biological replicate. Error bars indicate standard deviations. ** indicates
that ORCA2 transcript levels in the induced versus uninduced cultures of
a hairy root line carrying the binSRNA-ORCA2 construct differed by
p≤ 0.01, according to Student’s t-test.
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and then decline back to starting levels by the end of
the 72-h time course (Figure 4B). In contrast, ORCA2
endogenous gene transcript levels decline in the ORCA2-
OE cultures transferred to fresh media with no added
ethanol. These results suggest that ORCA2, directly or
indirectly, induces expression of the ORCA2 endogenous
gene, as cultures with high levels of expression of the
ORCA2 transgene express the endogenous ORCA2 gene
at higher levels than cultures with low levels of expression
of the ORCA2 transgene. Consistent with this hypothesis,
ORCA2 endogenous gene transcript levels are significantly
higher in ORCA2-OE cultures than in control cultures
at the 0 h time point, as ORCA2 transgene expression
is modestly induced in these ORCA2-OE cultures by plant-
produced ethanol. ORCA2 endogenous gene transcript
levels are not significantly different in uninduced versus
induced cultures of the control line.
Effects of ORCA2 overexpression on the indole and
terpenoid pathways
To determine if ORCA2 plays an important role in
regulation of the TIA pathway, transcript levels of 22
genes encoding key enzymes and regulators of the TIA
and related pathways were analyzed in the ORCA2-OE
and control hairy root lines. The genes analyzed include
ASα and TDC, two key genes from the indole pathway that
produces tryptamine; DXS, CPR, G10H and loganic acid
O-methyltransferase (LAMT) from the monoterpenoid
pathway which leads to the formation of secologanin; and
STR, SGD, T16H, 16OMT, D4H, DAT and PRX1 from
the TIA pathway which catalyzes the condensation of
tryptamine and secologanin and ultimately leads to the
production of vinblastine and vincristine. Transcript levels
of four transcriptional activators (ORCA2, ORCA3, CrBPF1
and CrMYC2) and five repressors (ZCT1, ZCT2, ZCT3,
GBF1 and GBF2) that regulate the TIA pathway were also
analyzed. To analyze the downstream effects of ORCA2
overexpression, the levels of 17 TIA and related metabolites
were also investigated, with 13 of those metabolites found
to be present at detectable levels in at least some of the
samples analyzed. Both transcript and metabolite levels
were tracked over a 72-h period following ethanol in-
duction of ORCA2 overexpression, to allow analysis of
both transient and relatively prolonged effects.
To characterize the effects of ORCA2 overexpression on
the indole pathway, ASα and TDC transcript levels were
analyzed. ASα encodes the α subunit of anthranilate
synthase, which catalyzes the first committed step in the
synthesis of tryptophan, the formation of chorismate from
anthranilate. TDC encodes tryptophan decarboxylase,
which catalyzes the conversion of tryptophan to tryptamine.
Both ASα and TDC transcript levels are significantly higher
in the ORCA2-OE line after ethanol induction than in
the uninduced ORCA2-OE cultures or in the induced or
uninduced cultures of the control line (Figure 5A and B).
ASα expression in the ORCA2-OE line increases within
12 h of the start of ORCA2 induction and then de-
creases slightly, but remains significantly higher than in
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Figure 4 Time course analysis of ORCA2 expression. ORCA2
transcripts generated from the endogenous ORCA2 gene and from
the ORCA2 transgene were measured separately by qPCR, using
primer pairs specific for each gene. The PCR primer pair used to
analyze ORCA2 transgene transcripts, as expected, gives only a very
low background signal for the control line (which lacks the ORCA2
transgene, data not shown). The lines analyzed are: uninduced
ORCA2-OE line (□, solid line), 0.02% ethanol-induced ORCA2-OE line
(■, solid line), uninduced control line (Δ, dashed line) and 0.02%
ethanol-induced control line (▲, dashed line). A) Relative ORCA2
transgene transcript levels are presented as ΔΔCT. Note that ORCA2
transgene transcript levels were normalized versus ORCA2
endogenous gene transcript levels in the uninduced control line at
0 h rather than against ORCA2 transgene transcript levels in the
uninduced control line at 0 h because the control line does not
carry the ORCA2 transgene. B) Relative ORCA2 endogenous gene
transcript levels are presented as ΔΔCT. Positive ΔΔCT values indicate
that ORCA2 endogenous gene transcript levels are higher in the
indicated hairy root line grown for the indicated time under the
indicated conditions than in the uninduced control line at 0 h.
Negative ΔΔCT values indicate the reverse. Results are the average
ΔΔCT value of three biological replicates, with two technical
replicates for each biological replicate. Error bars indicate
standard deviations. ORCA2 transcript levels in the induced versus
uninduced ORCA2-OE cultures differed at the same time point
with: * = p ≤ 0.05, ** = p ≤ 0.01 according to Student’s t-test.
Student’s t-test results for the induced versus uninduced cultures
of the control line are not depicted.
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the uninduced ORCA2-OE cultures or in the induced
or uninduced cultures of the control line. TDC tran-
script levels increase within 24 h and increase further
within 48 h after the start of ORCA2 induction. The
levels of tryptamine, the product of the indole pathway
that is combined with the terpenoid secologanin to form the
first TIA, strictosidine, were also analyzed in samples from
the same hairy root cultures. Tryptamine levels increase
significantly within 24 h of induction and remain increased
through 72 h. Tryptamine levels remain unchanged in
the uninduced ORCA2-OE cultures and the induced and
uninduced cultures of the control line (Figure 5C). Levels
of tryptophan were below detection limits.
To characterize the effects of ORCA2 overexpression on
the terpenoid pathway, the transcript levels of DXS, G10H,
CPR and LAMT were analyzed (Figure 6). Transcript levels
of DXS and CPR are not significantly different in the
induced ORCA2-OE line than in the uninduced ORCA2-
OE line (Figure 6A and C). In contrast, G10H transcript
levels in the ORCA2-OE line increase within 48 h after the
start of ORCA2 induction. Expression of LAMT increases
sharply in the ORCA2-OE line after induction, but then
decreases within less than 24 h, reaching levels that are
lower than those seen in uninduced ORCA2-OE cultures
within 72 h (Figure 6D). Addition of ethanol to the
“induced” control cultures had little affect on gene ex-
pression, indicating that differences in ethanol concen-
tration per se are not responsible for the differences in
gene expression observed for the induced versus uninduced
ORCA2-OE cultures. The differences in gene expression
Ct
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levels from the terpenoid pathway. Results shown are the:
uninduced ORCA2-OE line (□, solid line), 0.02% ethanol-induced
ORCA2-OE line (■, solid line), uninduced control line (Δ, dashed line)
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relative mRNA levels are presented as ΔΔCT. Results depicted are as
follows: A) DXS transcript levels, B) G10H transcript levels, C) CPR
transcript levels, D) LAMT transcript levels, E) loganin levels and
F) secologanin levels. Results for transcript levels are the average ΔΔCT
values of three biological replicates, with two technical replicates for
each biological replicate. Results for metabolite levels are the averages
of three biological replicates. Error bars indicate standard deviations.
Transcript levels of the indicated gene in the induced versus
uninduced ORCA2-OE cultures differed at the same time point
with: * = p≤ 0.05, ** = p≤ 0.01 according to a Student’s t-test. Similarly,
metabolite levels differed with: * = p≤ 0.1, ** = p≤ 0.05 according to
Student’s t-test. Student’s t-test results for the induced versus
uninduced cultures of the control line are not depicted.
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observed between the control and ORCA2-OE cultures
at the 0-h time point may be due to the fact that different
clonal root cultures have somewhat different growth
characteristics. Alternatively, some of these differences
may be due to the fact that the 35-d old ORCA2-OE
cultures from which the 0-h time point samples were
collected likely contained small amounts of root-produced
ethanol, which led to a modest induction of ORCA2
transgene expression.
The effects of ORCA2 overexpression on loganin and
secologanin levels were also determined. Loganin is the
precursor for secologanin, which is one of the precursors
for formation of the first TIA, strictosidine. Loganin levels
in induced and uninduced ORCA2-OE cultures are similar
(Figure 6E). In contrast, secologanin levels are somewhat
variable in the ORCA2-OE line. Secologanin levels are
significantly decreased in induced ORCA2-OE cultures
relative to uninduced ORCA2-OE cultures at 24 and 72 h
after induction, but are not significantly different at the
other time points assayed (Figure 6F).
Effects of ORCA2 overexpression on the TIA pathway
The first step in TIA synthesis, the condensation of
tryptamine and secologanin to form strictosidine, is
catalyzed by STR. SGD then uses strictosidine as a
substrate to form cathenamine, which serves as a substrate
for the formation of several TIAs via different branches
of the TIA pathway. To test if ORCA2 plays an important
role in regulating these processes, transcript levels for STR,
SGD, T16H, 16OMT, D4H, DAT and PRX1 were analyzed
in the ORCA2-OE and control hairy root lines for a 72-h
period following ORCA2 induction (Figure 7). The results
of these experiments indicate that transcript levels of six of
the seven genes tested are significantly affected by ORCA2
overexpression. STR,T16H and PRX1 are strikingly induced
by ORCA2 overexpression, although with somewhat differ-
ent timing and magnitudes. STR transcript levels increase
significantly in the ORCA2-OE cultures within 24 h of the
start of ORCA2 induction, reaching a maximum of approxi-
mately three times higher levels at the 48-h time point than
in the ORCA2-OE cultures at the zero time point. T16H
transcript levels also increase significantly within 24 h of
the start of induction, reaching levels by the 48 h time point
that are 20 to 30 times higher in the induced ORCA2-OE
cultures than in the uninduced ORCA2-OE cultures at
the same time point. PRX1 transcript levels increase
approximately 16 fold in the ORCA2-OE cultures within
12 h after the start of induction and then decline slightly.
D4H transcript levels are significantly higher in the induced
than in the uninduced ORCA2-OE cultures at 24 and 72 h
after the start of induction, but are only increased by
approximately two to four fold. Interestingly, transcript
levels of both SGD and DAT decrease in response to
ORCA2 overexpression. The timing of the declines in SGD
and DAT transcript levels are similar, with both genes
exhibiting significantly lower transcript levels in the
induced versus uninduced ORCA2-OE cultures within 12 h
of the start of induction. However, the magnitudes of the
changes in transcript levels are different, as SGD transcript
levels are only approximately two fold lower in the induced
versus uninduced ORCA2-OE cultures, whereas DAT tran-
script levels are approximately 15 to 40 fold lower in the in-
duced versus uninduced ORCA2-OE cultures. Of the seven
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Figure 7 Time course analysis of transcript levels of TIA
biosynthetic genes. Results shown are the: uninduced ORCA2-OE
line (□, solid line), 0.02% ethanol-induced ORCA2-OE line (■, solid line),
ethanol uninduced control line (Δ, dashed line) and 0.02%
ethanol-induced control line (▲, dashed line). The relative mRNA
levels are presented as ΔΔCT. Results depicted are as follows:
A) STR transcript levels, B) D4H transcript levels, C) SGD transcript levels,
D) DAT transcript levels, E) T16H transcript levels, F) PRX1 transcript
levels and G) 16OMT transcript levels. Results are the average ΔΔCT
values of three biological replicates, with two technical replicates
for each biological replicate. Error bars indicate standard
deviations. Transcript levels of the indicated gene in the induced
versus uninduced ORCA2-OE cultures differed at the same time
point with: * = p ≤ 0.05, ** = p ≤ 0.01 according to Student’s t-test.
Student’s t-test results for the induced versus uninduced cultures
of the control line are not depicted.
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TIA biosynthetic genes characterized, only 16OMT does
not show significant differences in expression levels
between uninduced and induced ORCA2-OE hairy root
cultures. The differences in expression of some of the
genes between the control and ORCA2-OE cultures at
the 0-h time point may be due to different clonal root
cultures having somewhat different growth characteristics
and/or to the fact that the ORCA2-OE cultures likely
expressed the ORCA2 transgene at modest levels at the
0-h time point due to the presence of small amounts of
root-produced ethanol in the 35-d old cultures from
which those samples were collected.
As ORCA2 overexpression causes significant alterations
in the transcript levels of a high percentage of the TIA
biosynthetic genes tested, it was of interest to determine if
ORCA2 overexpression also alters TIA levels. To address
this issue, the levels of 12 TIAs from different branches of
the TIA pathway were investigated in aliquots of the same
tissue samples used to analyze transcript levels. Nine of
these TIAs were present at detectable levels, whereas the
levels of the other three TIAs (vindoline, vinblastine
and vincristine) were below detection thresholds. In
addition, a tabersonine-like compound, designated Unk54,
was detected in the samples (Figure 8). The levels of
strictosidine, the first TIA to be formed from secologanin
and tryptamine, are significantly reduced in the induced
versus uninduced ORCA2-OE cultures within 24 h after
the start of induction and remain reduced throughout
the remainder of the 72-h time course. Ajmalicine and
serpentine are formed via the same branch of the TIA
pathway (Figure 1). Both ajmalicine and serpentine levels
exhibit modestly significant increases in the induced ver-
sus uninduced ORCA2-OE cultures 48 h after the start of
induction, but are not significantly different at the other
time points assayed. Catharanthine, the precursor for
vinblastine production, also exhibits modestly significantly
higher levels 48 h after induction, but not at the other
time points assayed. The levels of tabersonine, which is
the starting material for multiple branches of the TIA
pathway, are significantly reduced in induced versus
uninduced ORCA-OE cultures within 6 h of the start of
ORCA2 induction. Tabersonine is converted via one branch
of the TIA pathway to lochnericine and hörhammericine.
Lochnericine levels are not significantly altered by ORCA2
overexpression, but hörhammericine levels are significantly
reduced in the induced versus uninduced ORCA2-OE
cultures at 24 and 72 h after the start of induction.
Tabersonine is converted via a different branch of the TIA
pathway to 16-hydroxytabersonine (16OHTab). 16OHTab
levels exhibit modestly significant increases in the induced
versus uninduced ORCA2-OE cultures at 48 and 72 h
after the start of ORCA2 induction. Tabersonine is also
converted to 19-hydroxytabersonine (19OHTab). 19OHTab
levels increase within 12 h of the start of ORCA2 induction
and remain elevated for at least 72 h. Levels of vindoline,
the end metabolite of this branch of the TIA pathway and
precursor to vinblastine production, are below detection
limits. An un-identified metabolite, designated Unk54, was
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Figure 8 Time course analysis of TIA metabolite levels. Levels of
vindoline, vinblastine and vincristine were below detection
thresholds. Unk54 represents a tabersonine-like compound. Results
shown are the: uninduced ORCA2-OE line (□, solid line), 0.02%
ethanol-induced ORCA2-OE line (■, solid line), uninduced control line
(Δ, dashed line) and 0.02% ethanol-induced control line
(▲, dashed line). Levels of the following metabolites are presented:
A) tabersonine, B) ajmalicine, C) lochnericine, D) strictosidine,
E) hörhammericine, F) catharanthine, G) serpentine, H) 19OHTab,
I) 16OHTab and J) Unk54. Results are the average values of three
biological replicates. Error bars indicate standard deviations. Levels of
the indicated metabolite in the induced versus uninduced ORCA2-OE
cultures differed at the same time point with: * = p≤ 0.1, ** = p≤ 0.05
according to Student’s t-test. Student’s t-test results for the induced
versus uninduced cultures of the control line are not depicted.
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also detected in the tissue extracts. Based on its UV ab-
sorption spectra between 200 and 400 nm (data not shown),
Unk54 is a tabersonine-like compound. Unk54 levels
exhibit modestly significant increases in the induced
versus uninduced ORCA2-OE cultures at 48 h after the
start of induction, but not at the other time points assayed.
The levels of the pharmaceutically important TIAs vinblast-
ine and vincristine, formed by combining catharanthine
and vindoline, were below detection limits.
Effects of ORCA2 overexpression on regulators of the TIA
pathway
TIA production appears to be regulated via a complex
process. A number of transcriptional activators and repres-
sors have been identified [4-9], including the transcriptional
activators ORCA2, ORCA3, CrBPF1, CrMYC1, CrMYC2,
CrWRKY1 and CrWRKY2 and the transcriptional repres-
sors ZCT1, ZCT2, ZCT3, GBF1 and GBF2. To determine if
ORCA2 regulates TIA transcriptional regulators in addition
to TIA biosynthetic genes, transcript levels of ORCA3,
CrBPF1, CrMYC2, ZCT1, ZCT2, ZCT3, GBF1 and GBF2
were tracked for a 72-h time period in ethanol-induced
and uninduced ORCA2-OE and control hairy root cultures.
The results of these assays indicate that overexpression
of ORCA2 leads to increased transcript levels of the TIA
transcriptional activator ORCA3 in the induced versus
uninduced ORCA2-OE cultures (Figure 9). ORCA3 tran-
script levels in the induced ORCA2-OE cultures increase
significantly within 12 h of the start of induction and
remain elevated throughout the 72-h time course point,
compared with the uninduced ORCA2-OE cultures.
Overexpression of ORCA2 had minimal effects on CrMYC2
transcript levels, with the only significant difference
between the ORCA2-OE induced versus uninduced
cultures being a very modest decrease in CrMYC2
transcript levels at the 72-h time point. Interestingly,
overexpression of ORCA2 also causes increases in the
steady-state mRNA levels of the TIA transcriptional re-
pressors ZCT1, ZCT2 and ZCT3. The transcript levels
of these three zinc finger genes are significantly higher
in the induced versus uninduced ORCA2-OE cultures
within 12 h of the start of induction and remain elevated
through the 72-h time point for ZCT1 and ZCT2 and
through the 48-h time point for ZCT3. In contrast,
overexpression of ORCA2 has no significant effects on
transcript levels of CrBPF1, GBF1 or GBF2.
Discussion
ORCA2 is a key regulator of the TIA pathway
TIA biosynthesis in C. roseus is a complex, multi-step
process that is regulated by at least twelve transcriptional
regulators. The roles of most of these transcriptional
regulators, particularly with regards to the downstream
branches of the TIA pathway, remain to be determined
[4-9]. As the downstream branches of the TIA pathway
are responsible for production of several pharmaceutically
important compounds, this lack of information limits at-
tempts to develop models for regulation of TIA production.
Therefore, the effects of overexpressing ORCA2 on tran-
script levels of 22 TIA biosynthetic and regulatory genes
were characterized. The results of the research described
here indicate that ORCA2 overexpression in C. roseus hairy
roots significantly affects the transcript levels of several key
genes from both pathways leading to production of TIA
precursors, as well as six of the seven genes characterized
from the TIA pathway (Table 1). Overexpression of ORCA2
causes increased expression of both genes (ASα and TDC)
characterized from the indole pathway. Of the four genes
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Figure 9 Time course analysis of TIA regulatory gene
expression levels. Results shown are the: uninduced ORCA2-OE line
(□, solid line), 0.02% ethanol-induced ORCA2-OE line (■, solid line),
uninduced control line (Δ, dashed line) and 0.02% ethanol-induced
control line (▲, dashed line). The relative mRNA levels are presented
as ΔΔCT. Transcript levels are depicted for the following genes
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and H) GBF2. Results are the average ΔΔCT values of three biological
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according to Student’s t-test. Student’s t-test results for the induced
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from the monoterpenoid pathway that were characterized,
overexpression of ORCA2 causes increased expression
of G10H and LAMT, but does not significantly affect
transcript levels of DXS or CPR. Perhaps most interestingly,
overexpression of ORCA2 leads to significantly altered
transcript levels for almost all of the genes from the TIA
pathway that were characterized, including four out of
five genes characterized from the downstream branches
of the TIA pathway (Table 1). Overexpression of ORCA2
results in significantly increased transcript levels for STR,
which encodes the enzyme that catalyzes the first step in
TIA biosynthesis. Transcript levels of T16H, D4H and
PRX1 also increase in response to ORCA2 overexpression.
In contrast, transcript levels of 16OMT are not significantly
affected by ORCA2 overexpression. Somewhat surprisingly,
transcript levels of SGD and DAT decrease, rather than
increase, in response to ORCA2 overexpression. The effects
of ORCA2 overexpression on DAT transcript levels are
particularly striking, as DAT transcript levels are more
than 100 times lower in the ORCA2-OE line 12 h after
ethanol induction than in the control line at the zero
time point and 12 times lower than in the ORCA2-OE line
at the zero time point. These findings that overexpression
of ORCA2 causes significant alterations in transcript
levels for key genes from both feeder pathways, the gene
that encodes the enzyme that catalyzes the combination
of the products of those feeder pathways to form the first
TIA, the gene that encodes the enzyme that catalyzes
the conversion of the first TIA and four out of five
genes characterized from the downstream branches of
the TIA pathway indicates that ORCA2 plays a critical
role in regulation of TIA metabolism.
ORCA2 overexpression affects the levels of TIA and
related metabolites
Overexpression of ORCA2 also affects the levels of multiple
TIAs and related metabolites (Table 2). In characterizing
the indole pathway, tryptophan levels were found to be
below detection limits and tryptamine levels were found to
increase within 24 h in response to ORCA2 overexpression.
Higher tryptamine levels are consistent with the in-
creased ASα and TDC transcript levels caused by ORCA2
overexpression. ASα encodes the alpha subunit of anthra-
nilate synthase, which catalyzes the first committed step
in the tryptophan biosynthetic pathway and is feedback-
inhibited by tryptophan [36]. The concurrent increase
in TDC expression (Figure 5), however, increases the
Table 1 Effects of ORCA2 overexpression on regulation of
TIA and TIA-related biosynthetic genes and
transcriptional regulators
Transgene Result
ASα +
TDC +
DXS =
CPR =
G10H +
LAMT +
STR +
SGD -
T16H +
16OMT =
D4H +
DAT -
PRX1 +
ZCT1 +
ZCT2 +
ZCT3 +
GBF1 =
GBF2 =
ORCA2 +
ORCA3 +
CrBPF1 =
CrMYC2 -
“+” = up-regulation (transcript levels of indicated gene were higher at one or
more time points when ORCA2 was overexpressed); “-” = down-regulation
(transcript levels of indicated gene were lower at one or more time points
when ORCA2 was overexpressed). “=” = no change (transcript levels of indicated
gene were not significantly different when ORCA2 was overexpressed).
Table 2 Effects of ORCA2 overexpression on the levels of
selected metabolites in the TIA and feeder pathways
Transgene Result
Tryptophan BD
Tryptamine +
Loganin =
Secologanin -
Strictosidine -
Ajmalicine +
Serpentine +
Catharanthine +
Lochnericine =
Hörhammericine -
Tabersonine -
16-hydroxytabersonine +
19-hydroxytabersonine +
Vindoline BD
Vinblastine BD
Vincristine BD
“+” = level of indicated metabolite was higher at one or more time points
when ORCA2 was overexpressed; “-” = level of indicated metabolite was lower
at one or more time points when ORCA2 was overexpressed; “=” indicates no
significant change in metabolite level when ORCA2 was overexpressed; “BD”
indicates the metabolite was below detection levels.
Li et al. BMC Plant Biology 2013, 13:155 Page 10 of 17
http://www.biomedcentral.com/1471-2229/13/155
metabolic flux from tryptophan to tryptamine thus re-
ducing the feedback inhibition of anthranilate synthase
by tryptophan. In contrast, of the two metabolites from
the terpenoid pathway that were characterized, loganin
levels are not significantly affected and secologanin
levels are reduced at both the 24- and 72-h time points
in response to ORCA2 overexpression. Two factors may
account for the reduced secologanin concentration in
response to ORCA2 overexpression. One factor is that
ORCA2 overexpression has a smaller effect on the genes
in the terpenoid pathway (Figure 6) than on the genes in
the indole pathway (Figure 5). The other factor is that the
increase in STR expression (Figure 7) may result in more
rapid use of secologanin to form strictosidine.
The transgenic hairy root samples were also analyzed
for the levels of 13 TIAs or TIA-related compounds.
Three of these TIAs, vindoline, vinblastine and vincristine,
were present at levels below the detection threshold. The
levels of strictosidine, the first TIA produced by combining
the products of the indole and terpenoid pathways, are
significantly lower within 24 h of the beginning of ORCA2
overexpression. This result was somewhat unexpected
as the gene (STR) that encodes the enzyme that catalyzes
the formation of strictosidine is induced by ORCA2
overexpression and the gene (SGD) that encodes the
enzyme that converts strictosidine to cathenamine/4,21-
dehydrogeissoschizine/epicathenamine [12] is inhibited by
ORCA2 overexpression. However, decreased strictosidine
levels might be explained by the increased expression of
genes encoding enzymes for downstream steps, in the TIA
pathway, such as T16H and PRX1, causing an increased
rate of metabolite flux to the downstream part of the path-
way, in combination with the possibility of SGD not being
rate limiting for strictosidine metabolism. Alternatively,
the reduced SGD transcript levels caused by ORCA2
overexpression may not lead to similar decreases in SGD
activity levels. Consistent with the possibilities that SGD
activity levels are either not rate limiting or are not de-
creased, despite the decrease in SGD transcript levels,
are the findings that ajmalicine and serpentine are tran-
siently increased in response to ORCA2 overexpression.
Both ajmalicine and serpentine, which are made via the
same branch of the TIA pathway, are present in signifi-
cantly higher concentrations 48 h after the start of ORCA2
induction, but are not present at significantly altered levels
at the other time points assayed. Also consistent with these
possibilities are findings that ORCA2 overexpression leads
to transient increases in the levels of catharanthine, which
is made via a different branch of the TIA pathway, as
catharanthine levels are significantly increased 48 h after
the start of ORCA2 induction. The levels of tabersonine,
which is used as the starting material for multiple branches
of the TIA pathway (Figure 1), are decreased in response
to ORCA2 overexpression. Decreased tabersonine levels
in response to ORCA2 overexpression could be the result
of a decreased rate of tabersonine synthesis or an increased
rate of tabersonine metabolism. Consistent with the first
possibility is the finding that SGD transcript levels decrease
in response to ORCA2 overexpression, as SGD activity
is necessary for tabersonine production. However, the
decrease in SGD transcript levels first occurs at a later
time point than the decrease in tabersonine levels, making
the extent to which decreases in SGD transcript levels are
responsible for the decreased tabersonine levels unclear.
Increases in T16H transcript levels in response to ORCA2
overexpression are consistent with the possibility that
decreased tabersonine levels are due to a higher rate of
tabersonine metabolism, as T16H catalyzes the first step
for one branch of the TIA pathway, namely the conversion
of tabersonine to 16-hydroxytabersonine. However, T16H
transcript levels first increase at a later time point than
the decrease in tabersonine levels, making the extent to
which increases in T16H transcript levels cause decreased
tabersonine levels unclear. 16OMT catalyzes the conver-
sion of 16-hydroxytabersonine to 16-methoxytabersonine.
16OMT transcript levels are not significantly affected
by ORCA2 overexpression. As 16-hydroxytabersonine levels
increase within 48 h of the start of ORCA2 overexpression,
these results suggest that 16OMTactivity levels may be rate
limiting in hairy roots where ORCA2 is overexpressed.
Interestingly, the increase in 16-hydroxytabersonine levels
accounts for only a small portion of the substantial de-
crease in tabersonine levels, raising the possibility that
the levels of other tabersonine-related metabolites are
raised in response to ORCA2 overexpression. Consist-
ent with this possibility is the finding that the levels of
19OHTab, which is also made from tabersonine, in-
crease significantly in response to induction of ORCA2
overexpression. In addition, the identification of a
tabersonine-like compound, here designated Unk54,
that is present at significantly higher levels in ORCA2-OE
induced versus uninduced cultures is also consistent with
the idea that the levels of tabersonine-related metabolites in-
crease in response to ORCA2 overexpression. Lochnericine
and hörhammericine are also made from tabersonine, via
a different branch of the TIA pathway. Overexpression of
ORCA2 has no significant effects on lochnericine levels,
but leads to decreased hörhammericine levels at the
24- and 72-h time points, suggesting that overexpression
of ORCA2 causes an overall decrease in metabolic flux to
this branch of the TIA pathway.
ORCA2 regulates other TIA transcriptional regulators
As ORCA2 is believed to act as a transcriptional activator
[18], findings that overexpression of ORCA2 causes
significant decreases in SGD and DAT transcript levels
are somewhat surprising and suggest that regulation of
the TIA pathway is complex. A possible explanation for
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these results is that overexpression of ORCA2 may cause
increased expression of one or more TIA repressors. To
examine this possibility and to gain an increased under-
standing of TIA metabolic regulation, the transcript levels
of eight TIA regulatory genes, including all five of the
known TIA repressor genes, were examined (Figure 9).
ORCA2 overexpression causes increased transcript levels of
ORCA3. Interestingly, although overexpression of ORCA2
causes increased ORCA3 transcript levels, overexpression
of ORCA3 has no significant affects on ORCA2 transcript
levels [27]. These results suggest that, directly or indirectly,
ORCA2 regulates ORCA3 at the steady-state mRNA
level but that ORCA3 does not similarly regulate ORCA2.
ORCA2 also appears to, directly or indirectly, induce
its own expression. Hairy root cultures with higher levels
of ORCA2 transgene expression also have higher tran-
script levels from the endogenous ORCA2 gene. In
contrast, ORCA2 overexpression has little effect on
CrMYC2 transcript levels and no significant effects on
CrBPF1 transcript levels.
In addition to regulating some of the TIA transcriptional
activator genes, ORCA2 regulates the TIA transcriptional
repressor genes ZCT1, ZCT2 and ZCT3, but not GBF1 or
GBF2. These findings provide a possible explanation for
how overexpression of the ORCA2 transcriptional activator
gene may lead indirectly to decreased SGD and DAT tran-
script levels by causing overexpression of the ZCT1, ZCT2
and ZCT3 TIA transcriptional repressors, one or more of
which may then turn down expression of SGD and DAT. If
this model is correct, one might also expect overexpression
of ORCA2 to lead eventually to a decrease in expression of
TDC and STR, as the ZCTs have been shown to repress
expression of both these genes [19]. Although expression of
TDC and STR did decrease between the 48-h and 72-h
time points, these decreases were very slight. These results
may be due to the competing effects of ORCA2 induction
and ZCT repression on expression of TDC and STR. In
addition, differences in the half-lives of the transcripts pro-
duced by different genes will cause differences in the timing
with which decreases in gene transcript levels are observed.
Induction of ZCT1, ZCT2 and ZCT3 expression in re-
sponse to ORCA2 overexpression may help explain why
most of the observed alterations in TIA metabolite levels in
the ORCA2-induced cultures are transient. Interestingly,
overexpression of ORCA3 also results in increased tran-
script levels of specific TIA repressor genes [27].
Model for ORCA2 regulation of the TIA pathway
Based on the results of this study and of other studies,
a possible model for regulation of the TIA pathway by
ORCA2 has been developed (Figure 10). It should be
noted that the available data might also be consistent with
other models. In addition, ORCA2 might induce expression
of the indicated genes either directly or indirectly. For
example, ORCA2 might affect expression of some genes
indirectly, such as via effects on ORCA3 expression. In
the model presented, ORCA2 expression is induced via
the jasmonate-signaling pathway as a defense mechanism
against environmental stresses, such as insect attack or
fungal elicitation. Increased expression of ORCA2, as
well as signaling via the jasmonate-signaling pathway,
leads to increased expression of the ORCA3 transcrip-
tional activator. Whether induction of ORCA3 expression
via the jasmonate-signaling pathway occurs independently
of ORCA3 induction by ORCA2 is currently unclear.
Increased ORCA2 (this study) and ORCA3 [27] activity
levels then induce expression of partially overlapping
sets of key genes from the TIA pathway and both TIA
feeder pathways. The increased expression of the TIA
biosynthetic genes in turn affects the levels of several
TIAs and related metabolites, which may provide pro-
tection against the triggering environmental stress. At
approximately the same time that ORCA2 and ORCA3
are inducing expression of TIA biosynthetic genes, they
are also (directly or indirectly) inducing expression of the
TIA transcriptional repressors ZCT1, ZCT2 and ZCT3.
As the levels of these TIA transcriptional repressors
rise, they begin to decrease transcription of specific TIA
biosynthetic genes. As a result, induction of ORCA2 leads
Fungal 
elicitor 
ORCA2      ORCA3 
TIA biosynthetic genes ZCT1, ZCT2, ZCT3 
Jasmonate signal 
transduction 
Figure 10 Model for the role of ORCA2 in regulation of TIA
biosynthesis. A possible model for ORCA2 regulation of TIA
biosynthesis is presented. The signal triggered by binding of elicitors
activates the jasmonic acid signaling pathway, which then activates
ORCA2 and ORCA3. ORCA2 and ORCA3, together with other
transcriptional regulators (not shown), induce expression of specific
TIA biosynthetic genes. ORCA2 also, directly or indirectly, up-
regulates its own expression as well as expression of ORCA3. ORCA2
(this work) and ORCA3 [27] also, directly or indirectly, induce
expression of the ZCT1, ZCT2 and ZCT3 TIA transcriptional repressor
genes. As the activities of ZCT1, ZCT2 and ZCT3 increase they begin
to repress expression of particular TIA biosynthetic genes. As a result,
increased expression of ORCA2 or ORCA3 tends to cause increases
in TIA biosynthetic gene transcript levels and TIA metabolite levels
that are both transient and limited in magnitude.
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to alterations in the transcript levels of TIA biosynthetic
genes and in TIA metabolite levels that are often transient.
ORCA3 has been proposed to act in a similar manner [27].
This model for ORCA2 action is partially based on previous
findings on the role of ZCTs in repressing activation of
STR and TDC expression by the ORCAs [19], the fact that
the ZCTs are transiently induced by fungal elicitors or me-
thyl jasmonate [19,27] and characterization of the effects
of ORCA3 overexpression on expression of TIA regulatory
genes [27]. This model describes a mechanism whereby
alterations in TIA metabolite levels in response to en-
vironmental stresses may be regulated in such a way as
to be transient and of limited magnitude.
Conclusions
Although 12 TIA transcriptional regulators have been
identified, very few studies have been done on any of these
regulators, with the exception of ORCA3 [7-9,18-24].
Results presented here indicate that ORCA2 plays a critical
role in regulation of TIA metabolism. ORCA2 regulates
key genes from both feeder pathways, as well as the genes
(STR and SGD) encoding the enzymes that catalyze the
first two steps in TIA biosynthesis. ORCA2 may play
an especially important role in regulation of the down-
stream branches of the TIA pathway as it regulates
four out of five genes characterized from this part of
the pathway. Based on an analysis of the effects of ORCA2
overexpression on transcript levels of other TIA regulators,
a possible model for the mechanism by which ORCA2
helps regulate TIA metabolism has been developed
(Figure 10). This model, together with previous work
[27], describes a mechanism that allows alterations in
TIA metabolite levels in response to external stimuli to
be transient and limited in magnitude.
Methods
Materials and growth conditions
Catharanthus roseus, Vinca Little Bright Eye (www.neseed.
com), was used for these experiments. Seeds were sur-
face sterilized and germinated in Gamborg’s B5 medium
(Sigma, St. Louis, MO, USA) supplemented with Gamborg’s
vitamins (Sigma, St. Louis, MO, USA) in the dark at 26°C.
After two weeks, seedlings were shifted to a 16-h-light/
8-h-dark cycle with a light intensity of 44 μmol m-2 s-1
and grown for an additional 4 weeks prior to being inocu-
lated with Agrobacterium tumefaciens. The genes analyzed
in this study are: 16OMT [GenBank: EF444544], ASα
[GenBank: AJ250008], CPR [GenBank: X69791], CrBPF1
[GenBank: AJ251686], CrMYC2 [GenBank: AF283507.2],
D4H [GenBank: U71605], DAT [GenBank: AF053307], DXS
[GenBank: AJ011840], EF-1 [GenBank: EU007436], G10H
[GenBank: AJ251269], GBF1 [GenBank: AF084971],
GBF2 [GenBank: AF084972], LAMT [GenBank: EU057974],
ORCA2 [GenBank: AJ238740], ORCA3 [GenBank:
EU072424], PRX1 [GenBank: AM236087], SGD [GenBank:
EU072423], STR [GenBank: X53602], T16H [GenBank:
FJ647194], TDC [GenBank: X67662], UBQ11 [GenBank:
EU007433], ZCT1 [GenBank: AJ632082], ZCT2 [GenBank:
AJ632083], ZCT3 [GenBank: AJ632084].
Generation of ORCA2 overexpression construct
The current study employed an ethanol-inducible alc
gene expression system [34,37], generously provided by
Syngenta AG, which has been shown previously to be
effective in C. roseus hairy roots [32]. Total RNA was
isolated from C. roseus variety Little Bright Eye. cDNA
was generated from this RNA and the full-length coding
region of ORCA2 (AJ872340) was amplified using the
KOD Hot Start DNA polymerase (Novagen) and the
following oligonucleotides: 5′-ACCTGCAGGTCGACGAT
GTATCAATCAAATGCCCATAATTC-3′ (contains SalI
and PstI restriction endonuclease recognition sequences)
and 5′-ACCTGCAGGTCGTCTTATTGAGGACGAAGA
TGACACG-3′ (contains a PstI restriction endonuclease
recognition sequence). The PCR product was digested
with SalI and PstI before being cloned into a pACN vector
[34] that contains an ethanol-inducible promoter, AlcA.
The pACN plasmid with the ORCA2 coding region was
then digested into two fragments by HindIII. The frag-
ment carrying the ORCA2 gene and the AlcA promoter
was recovered and ligated into the destination vector
binSRNACatN [34]. The resulting construct, designated
binSRNA-ORCA2 (Figure 2), was used for transformation
of Agrobacterium tumefaciens GV3101.
Generation of transgenic hairy roots
To generate transgenic C. roseus hairy roots carrying
the ORCA2 coding region under the control of an
ethanol-inducible promoter, a mixture of cells containing
approximately equal numbers of Agrobacterium tumefaciens
GV3101 cells transformed with binSRNA-ORCA2 and
GV3101 carrying the pPZPROL plasmid were co-
transformed into 6-week old C. roseus seedlings as pre-
viously described [33]. The pPZPROL plasmid carries
the rol ABC genes, which are sufficient to induce hairy root
formation in C. roseus [33]. Approximately 4 weeks after
inoculation, hairy roots appeared on infection sites. When
the hairy roots were about 1 cm in length, roots were
excised from the seedlings and transferred onto a solid
medium containing 30 g L-1 sucrose, 6 g L-1 agar,
250 mg L-1 cefotaxime, half-strength Gamborg’s B5
salts and full-strength Gamborg’s vitamins (pH 5.8). Hairy
root selection started 1 week after roots were transferred
to the solid medium. To select hairy roots containing
the ORCA2 gene, 50 mg L-1 of kanamycin was used.
Root lines showing kanamycin-resistance were further
screened by using PCR to amplify the sequence that
spans the AlcA promoter and the ORCA2 gene (primers:
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5′-GGTACTGTCCGCACGGGATGTCCG-3′ and 5′-
TTATTGAGGACGAAGATGACACG-3′). Transgenic
hairy root lines showing positive results in both the
kanamycin-resistance and PCR amplification tests were
transferred to 50 mL of half-strength Gamborg’s B5 liquid
solution supplemented with full-strength Gamborg’s vi-
tamins and 30 g L-1 sucrose in a 250-mL flask for liquid
culture. The flasks were kept on a shaker at 225 rpm in
the dark and were sub-cultured every 5 weeks. To gen-
erate a control hairy root line, C. roseus seedlings were
transformed with GV3101 carrying only the pPZPROL
construct. A hairy root line that adapted well to liquid
media was selected for use as a control line in subse-
quent experiments.
Induction of transgene expression and tissue collection
To induce ORCA2 transgene expression, the liquid
media for dark-grown 35-d old ORCA2 transgenic
hairy root cultures (each started from five individual
hairy roots of 3–4 cm length) were replaced with fresh
aliquots of either the same liquid medium or the same
liquid medium supplemented with 0.02% ethanol.
The hairy roots were returned to the dark and were
harvested 0, 6, 12, 24, 48 and 72 h after the start of
induction (i.e. replacement of the media). Hairy roots
transformed with pPZPROL alone were used as a nega-
tive control and were treated the same way as the hairy
roots transformed with binSRNA-ORCA2 and pPZPROL.
Three independent hairy root cultures were harvested for
each transgenic hairy root line, time point and media
combination. Upon collection, hairy root samples were
immediately flash frozen using liquid nitrogen and then
stored at −80°C prior to being used in both the gene
expression and metabolite analyses.
RNA extraction and qRT-PCR analyses
Total RNA was extracted as previously described [38]
using the Spectrum Total RNA Isolation Kit (Sigma)
with on-column DNase I digestion. cDNAs were syn-
thesized using SuperScript II reverse transcriptase
(Invitrogen). ORCA2 and CrMYC2 transcript levels were
analyzed by qPCR using the SYBR Green JumpStart
Taq ReadyMix (Sigma, St. Louis, MO) and a Roche
LightCycler 480 II. For analysis of other genes, qPCR
assay design was performed using the Roche Universal
Probe Library (UPL) technology. Each assay design gen-
erated a sequence for the forward primer, reverse primer
and amplicon and provided the UPL probe number.
Quantitative PCR was performed on an ABI 7900 HT
(Applied Biosystems) with a 384-well ABI optical plate
using the Homebrew master mix (Biomedical Genomics
Center, University of Minnesota) and a Roche Universal
Probe (Roche Applied Science). Additional file 1 lists all
the primers and probes used for the qPCR reactions.
qPCR data were normalized by comparison to EF1 qPCR
results for the experiment depicted in Figure 3. For all
other experiments qPCR data were normalized using the
geometric average [39] of qPCR results for two control
genes, EF1 and UBQ11, which were shown previously to
be the two most stably expressed genes of those tested in
C. roseus [40]. For statements of fold changes, a change of
one Ct (i.e. a change of one PCR cycle) was estimated
to represent a two-fold change in transcript levels. For
the experiment depicted in Figure 4, relative ORCA2
transgene transcript levels were calculated as ΔΔCT.
ΔΔCT=ΔCTORCA2-endogenous in uninduced control roots at 0 h -
ΔCTother. ΔCTORCA2-endogenous in uninduced control roots at 0 h =
CTORCA2-endogenous in uninduced control roots at 0 h –
CTEF1/UBQ11 in uninduced control roots at 0 h. ΔCTother =
CTORCA2-transgene - CTEF1/UBQ11 for the same cDNA
sample (e.g. cDNA from an induced culture of the
ORCA2-OE line at the 24 h time point). Note that ORCA2
transgene transcript levels were normalized versus ORCA2
endogenous gene transcript levels in the uninduced control
line at 0 h rather than against ORCA2 transgene transcript
levels in the uninduced control line at 0 h because the
control line does not carry the ORCA2 transgene. Rela-
tive ORCA2 endogenous gene transcript levels were calcu-
lated as ΔΔCT. ΔΔCT =ΔCTORCA2-endogenous in uninduced
control roots at 0 h - ΔCTother. ΔCTORCA2-endogenous in uninduced
control roots at 0 h = CTORCA2-endogenous in uninduced control roots
at 0 h – CTEF1/UBQ11 in uninduced control roots at 0 h. ΔCTother. =
CTORCA2-endogenous – CTEF1/UBQ11 for the same cDNA
sample (e.g. cDNA from induced cultures of the ORCA2-
OE line at the 12 h time point). For the experiments
depicted in Figures 5, 6, 7 and 9, relative transcript levels
were also calculated as ΔΔCT. ΔΔCT=ΔCTuninduced control
roots at 0 h - ΔCTother. ΔCTuninduced control roots at 0 h =
CTindicated gene in uninduced control roots at 0 h – CTEF1/UBQ11 in
uninduced control roots at 0 h. ΔCTother = CTindicated gene – CTEF1/
UBQ11 for the indicated line at the indicated time point and
grown under the indicated conditions (e.g. for induced cul-
tures of ORCA2-OE harvested at the 48 h time point).
Metabolite extraction and analysis
Frozen hairy root tissue samples, collected as described
above, were lyophilized and ground to a powder. As
previously described [41], approximately 50 mg of the
freeze-dried and ground hairy roots were added to a
50-mL centrifuge tube and extracted with 10 mL of
methanol using a sonicating probe (Model VC 130 PB,
Sonics & Materials, Inc.) for 10 min while held on ice.
The extracts were then centrifuged at 4000 rpm for 12 min
at 15°C. The supernatant was removed and the biomass
was extracted one more time in the same manner. The
combined supernatants were passed through a 0.45 μm
nylon filter (25 mm, PJ Cobert), dried using a nitrogen
evaporator (Organomation Associates, Inc.), reconstituted
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in 2 mL of methanol, and passed through a 0.22 μm nylon
filter (13 mm, PJ Cobert) for HPLC analysis. Extracts
were stored at −25°C.
Twenty microliters of the alkaloid extract was injected
into a Phenomenex Luna C18(2) column (250 × 4.6 mm)
using three solvent systems. The Waters high perform-
ance liquid chromatography system consisted of a 1525
binary pump, a 717plus Autosampler, and a 996 Photo
Diode Array (PDA) detector. For the measurement
of tryptophan (Sigma, St. Louis, MO) and tryptamine
(Sigma, St. Louis, MO), a previously described method was
used with UV detection at 218 nm [42]. Quantification
was performed by comparison to standard curves. For
detection of iridoid glycosides a second solvent system
was used. Data extracted at 239 nm were used to quantify
loganin (Fluka/Sigma, St. Louis, MO) and secologanin
(Fluka/Sigma, St. Louis, MO). The previously described
method [41] was adapted from two previously published
protocols [43,44]. For 30 min, at a flow rate of 1 mL min-1,
the mobile phase was linearly ramped from a 90:10 to a
75:25 mixture of 1% formic acid (v/v)/0.25% trichloroacetic
acid (w/v):acetonitrile. The ratio was then returned to
90:10 and the column was allowed to re-equilibrate. For
the detection of TIAs, a third solvent system was used
following a previously described method [41]. Data
extracted at 254 nm were used to quantify strictosidine
(gift from Dr. O’Connor, John Innes Centre, UK), ajmalicine
(Fluka/Sigma, St. Louis, MO), serpentine (Sigma-Aldrich,
St. Louis, MO), catharanthine (Qventas, Branford, CT),
vindoline (ChemPacific Corp., Baltimore, MD), vinblastine
(Sigma, St. Louis, MO) and vincristine (Sigma, St. Louis,
MO) using standard curves. Data extracted at 329 nm
were used to quantify tabersonine (in-house standard),
hörhammericine (in-house standard), lochnericine (in-
house standard), 19OHTab (in-house standard), 16OHTab
(in-house standard), and Unk54 using retention time
standards, photodiode array detection, and a comparison to
a tabersonine standard curve [45-49]. In house standards of
19OHTab and 16OHTab were generated from S. cerevisiae
strains expressing TL19H and T16H genes respectively,
and identified using LC-MS and NMR (Additional file 2).
Metabolite levels were determined based on peak area,
with the exception of loganin, which was quantified
based on peak height. The third protocol was adapted
from a previously published protocol [42] to use LC-MS
compatible solvents. 19OHTab and 16OHTab were verified
by LC-MS analysis utilizing an Agilent Technologies 1100
series liquid chromatography (LC) system with a binary
pump, a temperature–controlled autosampler and a diode-
array detector mated with an Agilent MSD model SL ion
trap mass spectrometer (MS). 10 μL of the alkaloid extract
was injected into the LC-MS system with a Phenomenex
Luna C18(2) column (150 × 2.0 mm). The LC-MS protocol
is adapted from the third solvent system of HPLC methods
for a smaller diameter of column. The mass spectrom-
eter was operated in positive ion mode and full scan
data was collected between 50 and 700 m/z. Operation
and analyses were performed with ChemStation software
(Agilent Technologies, Santa Clara, CA). The LC-MS
analysis was performed at the W. M. Keck Metabolomics
Research Laboratory. Unk54 was verified as tabersonine-
like using its UV absorbance spectra as collected by the
PDA. For quantification, a molecular weight of 352.43 was
assumed, the same as the molecular weight of lochnericine,
16OHTab, and 19OHTab.
Statistical analyses
A two-tailed Student’s t-test was used for data analyses.
Significant differences were determined based on com-
parison of results obtained for the ethanol-induced versus
uninduced cultures of the ORCA2 transgene-containing
line at each time point. For transcriptional profiling experi-
ments, (**) was used to represent p ≤ 0.01 and (*) was used
to represent p ≤ 0.05. For metabolite profiling experiments,
(**) was used to represent p ≤ 0.05 and (*) was used to
represent p ≤ 0.1.
Additional files
Additional file 1: Primer pairs and probes used for qPCR analyses.
This table provides the sequences of the oligonucleotides used as
primers to amplify cDNAs during qPCR analyses. This table also provides
the numbers of the probes from the Roche Universal Probe Library used
during qPCR analyses.
Additional file 2: Alkaloid identification and quantification. This
document provides information about the generation of the 16OHTab and
19OHTab standards. Additional File 2 also provides information regarding
the 16OHTab spectra, UV absorbance properties and MS/MS fragment
patterns of the metabolites analyzed in this study, and 16OHTab and
19OHTab MS and MS/MS spectra and 16OHTab NMR spectra.
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